Medifast (MED) Tops Q4 EPS by 19c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $12.17 +0.58%
EPS Growth %: -195.2%
Financial Fact:
Selling, general, and administration: 43.21M
Today's EPS Names:
PBCO, SICP, MNSB, More
EPS Growth %: -195.2%
Financial Fact:
Selling, general, and administration: 43.21M
Today's EPS Names:
PBCO, SICP, MNSB, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q4 EPS of $1.09, $0.19 better than the analyst estimate of $0.90. Revenue for the quarter came in at $191 million versus the consensus estimate of $184.17 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bloom Energy shares fall despite beating Q3 estimates
- MaxLinear (MXL) Tops Q3 EPS by 6c; Offers Outlook
- Community West Bancshares (CWBC) Misses Q3 EPS by 27c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
